127 related articles for article (PubMed ID: 12023010)
1. Transforming growth factor alpha protects against Fas-mediated liver apoptosis in mice.
Kanda D; Takagi H; Toyoda M; Horiguchi N; Nakajima H; Otsuka T; Mori M
FEBS Lett; 2002 May; 519(1-3):11-5. PubMed ID: 12023010
[TBL] [Abstract][Full Text] [Related]
2. Novel role for amphiregulin in protection from liver injury.
Berasain C; García-Trevijano ER; Castillo J; Erroba E; Santamaría M; Lee DC; Prieto J; Avila MA
J Biol Chem; 2005 May; 280(19):19012-20. PubMed ID: 15753092
[TBL] [Abstract][Full Text] [Related]
3. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.
de la Coste A; Fabre M; McDonell N; Porteu A; Gilgenkrantz H; Perret C; Kahn A; Mignon A
Am J Physiol; 1999 Sep; 277(3):G702-8. PubMed ID: 10484397
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.
Lacronique V; Mignon A; Fabre M; Viollet B; Rouquet N; Molina T; Porteu A; Henrion A; Bouscary D; Varlet P; Joulin V; Kahn A
Nat Med; 1996 Jan; 2(1):80-6. PubMed ID: 8564847
[TBL] [Abstract][Full Text] [Related]
6. A Bcl-2 transgene expressed in hepatocytes does not protect mice from fulminant liver destruction induced by Fas ligand.
Loo Gv; Lippens S; Hahne M; Matthijssens F; Declercq W; Saelens X; Vandenabeele P
Cytokine; 2003 May; 22(3-4):62-70. PubMed ID: 12849704
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA
Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950
[TBL] [Abstract][Full Text] [Related]
8. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection.
Rodriguez I; Matsuura K; Khatib K; Reed JC; Nagata S; Vassalli P
J Exp Med; 1996 Mar; 183(3):1031-6. PubMed ID: 8642244
[TBL] [Abstract][Full Text] [Related]
9. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
Hatano E; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.
Kovalovich K; Li W; DeAngelis R; Greenbaum LE; Ciliberto G; Taub R
J Biol Chem; 2001 Jul; 276(28):26605-13. PubMed ID: 11349125
[TBL] [Abstract][Full Text] [Related]
11. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway.
Faouzi S; Burckhardt BE; Hanson JC; Campe CB; Schrum LW; Rippe RA; Maher JJ
J Biol Chem; 2001 Dec; 276(52):49077-82. PubMed ID: 11602613
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes.
Woo M; Hakem A; Elia AJ; Hakem R; Duncan GS; Patterson BJ; Mak TW
J Immunol; 1999 Nov; 163(9):4909-16. PubMed ID: 10528193
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor.
Kosai K; Matsumoto K; Nagata S; Tsujimoto Y; Nakamura T
Biochem Biophys Res Commun; 1998 Mar; 244(3):683-90. PubMed ID: 9535725
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
[TBL] [Abstract][Full Text] [Related]
16. Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver.
Hikita H; Takehara T; Shimizu S; Kodama T; Li W; Miyagi T; Hosui A; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Yin XM; Hennighausen L; Tatsumi T; Hayashi N
Hepatology; 2009 Oct; 50(4):1217-26. PubMed ID: 19676108
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1beta protects mice from Fas-mediated hepatocyte apoptosis and death.
Takehara T; Hayashi N; Tatsumi T; Kanto T; Mita E; Sasaki Y; Kasahara A; Hori M
Gastroenterology; 1999 Sep; 117(3):661-8. PubMed ID: 10464143
[TBL] [Abstract][Full Text] [Related]
18. Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity.
Hanson JC; Bostick MK; Campe CB; Kodali P; Lee G; Yan J; Maher JJ
J Hepatol; 2006 Feb; 44(2):359-67. PubMed ID: 16168518
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis.
Takahashi M; Saito H; Okuyama T; Miyashita T; Kosuga M; Sumisa F; Yamada M; Ebinuma H; Ishii H
J Hepatol; 1999 Aug; 31(2):315-22. PubMed ID: 10453946
[TBL] [Abstract][Full Text] [Related]
20. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
